Aurinia legal chief sells 11,867 shares for taxes
Sentiment and the balance of points
Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.
Rhea-AI Filing Summary
Aurinia Pharmaceuticals Inc. Chief Legal Officer Stephen P. Robertson reported that 11,867 common shares were automatically sold on November 13, 2026, to cover tax withholding. The weighted-average price was $15.97 per share, with transactions ranging from $15.95 to $16.00. After the sale, he directly held 576,981 shares. The shares related to vesting of Performance Stock Units from the February 28, 2025 performance award; no Rule 10b5-1 plan is reported.
Insider Trade Summary
| Type | Security | Shares | Price | Value |
|---|---|---|---|---|
| Sale | Common Stock F1, F2 | 11,867 | $15.97 | $190K |
Footnotes (2)
- F1. Represents the number of shares automatically sold to cover tax withholding obligations in connection with the vesting of Performance Stock Units (PSUs) related to the February 28, 2025 performance award.
- F2. The price in column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $15.95 to $16.00, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range.
Key Figures
Key Terms
Performance Stock Units (PSUs) financial
weighted average price financial
tax withholding obligations financial
FAQ
AI-generated questions and answers. How Rhea-AI works. Not financial advice.
AI-generated analysis. How Rhea-AI works. Not financial advice.